From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Magnolia Capital Fund.

The investment firm revealed a purchase of $2.5 million in America’s Car-Mart Inc $CRMT.

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Farhad Nanji, director at RXO Inc $RXO.

Nanji revealed a purchase of 747,424 RXO shares, equivalent to $15 million.

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Warren Buffett and Berkshire Hathaway.

Buffett and Berkshire reported another substantial purchase in Occidental Petroleum Corp $OXY, this time with a total value of $245  million.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes via Form 4 filings by Warren Buffett and Berkshire Hathaway.

Buffett and Berkshire reported additional purchases in The Liberty SiriusXM Group  for a total amount of $55,438,736.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by Maha Katabi, director of Vera Therapeutics $VERA.

Katabi reported a purchase of 161,290 VERA shares, equivalent to $5 million.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by Gilead Sciences.

The American biopharmaceutical company revealed a purchase of roughly $320 million in Arcus Biosciences Inc $RCUS, increasing its ownership stake to 40%.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by GSK plc.

The British multinational pharmaceutical company reported a purchase of $16.5 million in Wave Life Sciences Ltd $WVE.

From the Desk of Steve Strazza and Alfonso Depablos

Cathie Wood’s ARK Investment Management is on our list today, as it just filed multiple 13G filings on the following stocks:

• Teladoc Health, Inc $TDOC, increasing its ownership stake from 11.43% to 12.82%;
• Intellia Therapeutics, Inc $NTLA, increasing its ownership stake from 10.52% to 12.74%;
• Recursion Pharmaceuticals, Inc $RXRX, initiating a 9.92% stake;
• Verve Therapeutics, Inc $VERV, increasing its ownership stake from 5.43% to 8.84%;
• Ginkgo Bioworks Holdings, Inc $DNA, increasing its ownership stake from 8.92% to 12.26%; and
• Twist Bioscience Corp $TWST, increasing its ownership stake from 11.60% to 12.51%.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by Elias Sabo, director and CEO of Compass Group Diversified Holdings LLC $CODI.

Sabo reported an aggregate CODI purchase worth roughly $2 million.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by Warren Buffett and Berkshire Hathaway.

Buffett and Berkshire reported additional purchases in The Liberty SiriusXM Group $LSXMA for a total amount of $44,659,853.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Fairmount Healthcare Fund II L.P.

The investment firm revealed a purchase of 476,190 shares of Viridian Therapeutics Inc $VRDN, equivalent to $9.9 million.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Joseph D. Samberg, director of NextNav Inc $NN.

Samberg revealed a purchase of $1,172,775 worth of NN shares.